The effects of isoflavones on bone density in postmenopausal women at tertiary centre
Keywords:Isoflavones, Phytoestrogens, Bone density
Background: The objective of study was to study the effect of isoflavone supplement on bone density of postmenopausal women.
Methods: Women aged 49–65 y (n = 205) were enrolled in a double-blind, prospective randomized, placebo-controlled trial; 177 completed the trial. Bone density, body composition, bone turnover markers and diet were measured at baseline and after 12 months.
Results: Loss of lumbar spine bone mineral content and bone mineral density was significantly lower in the women taking the isoflavone supplement than in those taking the placebo. Interactions between treatment group and menopausal status with respect to changes in other outcomes were not significant.
Conclusions: These data suggest that, through attenuation of bone loss, isoflavones have a potentially protective effect on the lumbar spine and femur neck in women.
NIH consensus development panel on osteoporosis prevention, diagnosis and therapy. South Med J. 2001;94:569-73.
Sowers MF, Galuska DA. Epidemiology of bone mass in premenopausal women. Epidemiol Rev. 1933;15:374-98.
Khan AA, Syed Z. Bone densitometry in premenopausal women: synthesis and review. J Clin Densitom. 2004;7(1):85-92.
Mann GB , Kang YC,Brand C, Ebeling PR ,Miller JA. Secondary causes of low bone mass in patients with breast cancer. A need for greater vigilance. J Clin Oncol. 2009;18(4):85-9.
Vatanparast H, Chilibeck PD. Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-produsing phenotype? Nutr Rev. 2007;65(6 Pt-1):294-9.
Fragakis AS. The Health Professionals Guide to popular Dietary Supplements. 2nd edition. Chicago IL: American Dietetic Association, 2003.